v3 Template
B

BioGeneration Ventures

Life Sciences / Biotechnology ~860 employees
Founded
--
Employees (Est.)
~860
43 leaders known
Total Funding
$163.5M
Funding Rounds
1
Last Funding
2023-07-13

About BioGeneration Ventures

BioGeneration Ventures (BGV) is a venture capital firm focused on shaping and funding early-stage life sciences companies in Europe. With extensive experience in pharma and biotech, BGV leverages its industry network to accelerate product development and transform companies into attractive investment opportunities.

Products & Services

Seed Investment for Life Sciences Companies:BGV specializes in providing early-stage funding as a lead investor for innovative biotech companies addressing high unmet medical needs.
Portfolio Company Support:BGV offers hands-on operational and management expertise to portfolio companies, aiding in product development and business growth.
Avidicure:Developing novel approaches for immune cell activation and stimulation.
Scenic Biotech:Develops a technology platform to discover disease suppressor genes.
Tanai Therapeutics:Developing a small molecule for a genetically validated target to increase energy expenditure in obesity.
Tessellate Bio:Redefining synthetic lethality in cancer beyond homologous recombination deficiency.

Specialties

Early-stage funding Seed investment Biotech product development Venture capital in life sciences Operational and management expertise

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Venture Capital Fund
T: -
FT: Venture Capital Fund
A: 163500000
MR: -
FA: €150 million
FAN: 163500000
D: 2023-07-13
FD: 2023-07-13
4 investors
Venture Capital Fund Latest
2023-07-13
$163.5M
4 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

R

Rianne Ellenbroek

Principal

LinkedIn (Pro only)
L

Lars Erwig

Senior Advisor

LinkedIn (Pro only)
C

Claire van Viersen

Executive Assistant

LinkedIn (Pro only)
R

Rachelle Young

Investor Relations Director

E

Ed Snowden

T

Tim Berners-Lee

View 40 more team members with Pro

Unlock Full Team Directory

Recent News

BioGeneration Ventures Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Life Sciences / Biotechnology
Company Size
~860 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro